Navigation Links
Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
Date:12/13/2008

HUNTINGTON BEACH, California and AMSTERDAM, December 13 /PRNewswire/ -- Dr. Michael Knauer from the Netherlands Cancer Institute today announced data uncovering a substantial group of traditionally miscategorized low risk HER2+ patients. Agendia's highly accurate breast cancer tumor recurrence test, MammaPrint(R), was used to differentiate between patients at high and low risk for recurrence.

HER2+ patients are commonly identified as high risk, yet MammaPrint was able to identify a low risk subgroup of HER2+ patients, who subsequently experienced a 10 year disease-free survival of close to 90 percent even in the absence of (neo)adjuvant trastuzumab (Herceptin(R)) and chemotherapy. Additionally, in a subgroup of highly endocrine responsive HER2/NEU positive patients, MammaPrint(R) low risk patients had no relapse.

The results were presented by Dr. Michael Knauer during the 2008 San Antonio Breast Cancer Symposium (SABCS). In the study population of 169 HER2+ patients MammaPrint(R) classified 16 percent of patients as having a good prognosis signature with a 10-year distant disease-free survival (DDFS) of 89 percent, compared to 84 percent of patients classified as having a poor prognosis signature with a DDFS of 64 percent.

MammaPrint(R)'s robustness is underscored by the 70 gene panel unique to the test and a resulting gene profile that covers all molecular pathways associated with breast cancer. HER2/NEU-overexpression is observed in 15-20 percent of invasive breast cancers and is widely considered to be a negative prognostic factor. As a result, current treatment guidelines classify all HER2-positive breast cancer patients at high risk of relapse, and recommend trastuzumab and chemotherapy.

MammaPrint(R) accurately identified a subgroup of patients with a good clinical outcome in HER2+ early breast cancer. These patients will be further studied in the ongoing MINDACT-trial (Microarra
'/>"/>

SOURCE Agendia BV
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
2. New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
3. Agendias MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
4. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
5. New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
6. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
7. New Breast Imaging Technology Targets Hard-to-Detect Cancers
8. New Mammography Technology Effective in Detecting Breast Cancer
9. Siemens Introduces New Standard of Care for Breast Ultrasound
10. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
11. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... UBS Global Healthcare Conference in New York ... at 11 a.m. Eastern Time. To listen to the ... the Investor Relations section of the Company,s Web site at ... days after the event. About Orexigen® Therapeutics ...
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology Inc. ... Sorter 8-well strip holder and 130um sorting chip.  Sony will ... collected on its new SH800 Cell Sorter, the EC800 flow ... commercial tutorials at CYTO 2013, which will be held at ... San Diego, California , from May 20 ...
(Date:5/17/2013)... , May 17, 2013 ... health economics and outcomes research also   to   ... NASDAQ: SHPG ), the global specialty biopharmaceutical ... 7 poster presentations at the American Psychiatric Association (APA) ... , May 18-22. The data being presented represent Shire,s ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... Calif., July 27, 2011 Varian Medical Systems (NYSE: ... operations of $0.83 per diluted share in the third quarter ... the year-ago quarter.  Revenues for the quarter were $649 million, ... percent on a constant currency basis.  Order backlog at the ...
... PDL BioPharma, Inc. (PDL) (NASDAQ: ... ended June 30, 2011. Total revenues for the ... for the same period of 2010, a one percent year-over-year increase. ... $205.5 million, compared to $182.4 million for the same period of ...
Cached Medicine Technology:Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011 7PDL BioPharma Announces Second Quarter 2011 Financial Results 2PDL BioPharma Announces Second Quarter 2011 Financial Results 3PDL BioPharma Announces Second Quarter 2011 Financial Results 4PDL BioPharma Announces Second Quarter 2011 Financial Results 5PDL BioPharma Announces Second Quarter 2011 Financial Results 6PDL BioPharma Announces Second Quarter 2011 Financial Results 7PDL BioPharma Announces Second Quarter 2011 Financial Results 8PDL BioPharma Announces Second Quarter 2011 Financial Results 9PDL BioPharma Announces Second Quarter 2011 Financial Results 10
(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...
(Date:5/18/2013)... May 18, 2013 During Better Hearing ... should consider the legal protections they have, including the ... arise with their child’s treatment or hearing aid device, ... 1927, the American Speech-Language-Hearing Association has used the month ... to promote treatment, such as cochlear implants, which can ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with synthetic ... landing in emergency rooms across America. Recovery ... with a new treatment program for those addicted to ... the National Institute on Drug Abuse, synthetic marijuana has ... In 2012, 11 percent of high school seniors had ...
(Date:5/18/2013)... May 18, 2013 The American ... John A. Kitzhaber, M.D., (D) to sign a bill ... prohibiting minors under the age of 18 from tanning ... the third state in the nation to enact an ... similar indoor tanning bans for minors. Nationwide, 34 states ...
(Date:5/18/2013)... The topics that will be covered in the 1-day ... meetings, scrum artifacts, and scrum simulation (optional). One can earn ... These trainings are suitable for business analysts, project managers, developers, ... will be a part of the Scrum team, people outside ... and Scrum, but are unsure of what it is. ...
Breaking Medicine News(10 mins):Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3
... Justin Timberlake; Sam, Younes and David Nazarian; and Sandy and ... at their annual Gala on Wednesday, November 4, 2009 at ... The event, sponsored by Lexus, benefitted the Cedar-Sinai Board of ... for the cause. , Justin Timberlake was ...
... YORK, Nov. 5 Wolters Kluwer Health has announced the ... the new position of Chief Nursing Officer (CNO) in a ... & Wilkins (LWW) journals and Ovid brands. LWW is a ... the global leader in electronic medical, scientific, and academic information ...
... Corporation (NYSE: KMB ) today announced the expiration ... Act with respect to its previously announced planned acquisition ... cash tender offer on October 20, 2009 to purchase ... tender offer will expire at midnight on November 17, ...
... Nov. 5 Narconon International,s management office in Los ... throughout the country in a combined effort to speak ... Red Ribbon Week. , The National Family Partnership,s (NFP) ... drug prevention activities and is held during the end ...
... Executive Vice President of the University of Pennsylvania for ... receive the Abraham Flexner Award for Distinguished Service to ... (AAMC). The award will be presented on Saturday, Nov. ... The Flexner Award was established by the ...
... ... increase awareness about the disease, raise funds for The Association’s global research program through an ... patients.” , ... (Vocus) November 5, 2009 -- As every caregiver who helps take care of someone living ...
Cached Medicine News:Health News:2009 Cedars-Sinai Board of Governors Gala Sponsored by Lexus Raises Over $2.6 Million 2Health News:Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer; Strengthens Its Commitment to the Nursing Market 2Health News:Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer; Strengthens Its Commitment to the Nursing Market 3Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 2Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 3Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 4Health News:Narconon Centers Educate Thousands During Red Ribbon Week 2Health News:Penn's Arthur H. Rubenstein receives Distinguished Service award from AAMC 2Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 2Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 3Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 4Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 5
... color perception charts are recognized internationally ... determining color deficiency. With normal color ... all be visible. Each color test ... is specially printed to measure incrementally ...
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
... BD Edgeahead Stiletto / MVR knife. 1.1 ... insertion of 1.1 mm (19G) Cannula (5/bx, 1 ... knives are consistently sharp and precise. Sure grip ... edge. Tapered tip creates a fluid tight incision ...
Medicine Products: